ADVANCE SOLID TUMORS

Clinical trials for ADVANCE SOLID TUMORS explained in plain language.

Never miss a new study

Get alerted when new ADVANCE SOLID TUMORS trials appear

Sign up with your email to follow new studies for ADVANCE SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New cancer drug ALK-N001 enters early human testing

Disease control Terminated

This early-phase trial tests a new drug called ALK-N001 in people with advanced solid tumors, including esophageal, lung, and stomach cancers. The main goals are to check safety, find the right dose, and see how the drug moves through the body. Only 16 participants were enrolled,…

Matched conditions: ADVANCE SOLID TUMORS

Phase: PHASE1 • Sponsor: Zhejiang Anglikang Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:09 UTC

ADVANCE SOLID TUMORS

Get alerted when new ADVANCE SOLID TUMORS trials appear

New cancer drug ALK-N001 enters early human testing